ReviewMagyar onkologia2025
New Perspectives and State of the Art in Interventional Radiotherapy (Brachytherapy) for Head and Neck Tumors.
Review in Magyar onkologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThis review aims to evaluate the role of interventional radiotherapy (IRT - brachytherapy) in the clinical management of head and neck (H&N) cancers, focusing on recent technological advancements and their impact on clinical outcomes.
methodsA comprehensive literature review of clinical applications of IRT in H&N cancers was conducted, emphasizing the role of advanced imaging intensity-modulated IRT and custom applicators. The role of artificial intelligence and several dose calculation algorithms in treatment planning was also analyzed.
resultsIRT demonstrated efficacy across primary treatment, postoperative settings, and reirradiation, offering precise dose delivery while sparing adjacent healthy tissues. Innovations such as image-guided techniques and personalized 3D-printed applicators improved dosimetric accuracy and reduced toxicity. Functional outcomes were particularly favorable in sensitive anatomical regions like the nasal vestibule and oral cavity.
conclusionsIRT remains a cornerstone of precision oncology for head and neck cancers, achieving high efficacy, reduced toxicity, and improved patient quality of life. These advancements highlight its crucial role in modern oncologic care.
Indexed as
Identifiers
40643451PMC12255509What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.